Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Need for Desire Drugs Debated.

Jan Greene

    Managed Care (Langhorne, Pa.)
    |March 9, 2017
    PubMed
    Summary

    Low libido in women is a complex issue. The debate includes whether female sexual response is spontaneous or responsive, impacting treatment markets.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Even Small Employers Are Striking Out on Their Own.

    Managed care (Langhorne, Pa.)·2019
    Same author

    EDs Getting Ready To Dive Into Value-based Payment Waters.

    Managed care (Langhorne, Pa.)·2019
    Same author

    Interopera-impossibility?

    Managed care (Langhorne, Pa.)·2019
    Same authorSame journal

    Air Ambulance Turbulence: Consolidation, Cost Shifting, and Surprise Billing.

    Managed care (Langhorne, Pa.)·2019
    Same author

    The Growing Appeal of On-the-job Health Care.

    Managed care (Langhorne, Pa.)·2019
    Same author

    HRT Has an Uncertainty Problem. Does Compounding Make It Worse?

    Managed care (Langhorne, Pa.)·2019

    Area of Science:

    • Women's sexual health
    • Pharmacology
    • Human sexuality

    Background:

    • The market for female low libido treatments, like Addyi, faces challenges despite perceived demand.
    • Questions arise about the medicalization of normal sexual experiences.
    • Understanding the nature of female sexual response is crucial.

    Purpose of the Study:

    • To explore the debate surrounding the medicalization of low libido in women.
    • To examine the differing perspectives on female sexual response (spontaneous vs. responsive).

    Main Methods:

    • Literature review and synthesis of existing research on female sexual response.
    • Analysis of market trends and sales data for relevant pharmaceuticals.
    • Examination of societal and medical perspectives on female sexual dysfunction.

    Main Results:

    • Sales of Addyi have been slower than anticipated, suggesting market complexities.
    • The debate on spontaneous versus responsive sexual desire in women remains a key factor.
    • There is ongoing discussion regarding the medicalization of typical sexual experiences.

    Conclusions:

    • The market for female libido medications is not straightforward.
    • Further research is needed to understand the nuances of female sexual response.
    • A critical evaluation of medicalizing normal sexual experiences is warranted.

    Related Experiment Videos